Pediatric Trial Network: Hypertension in Children after Kidney Transplant

Pediatric Trials Network (PTN) – Lisinopril Trial

Study Overview

This study is being done to learn more about the dosing, safety, and side effects of the blood pressure medicine, lisinopril, in children (2 to 17 years old) with kidney transplants. The lisinopril will be given for about two weeks.

Eligibility Criteria

1. Kidney transplant recipient
2. Age 2-17 years
3. Estimated GFR (eGFR) ≥30 ml/min/1.73m2
4. Systolic BP >90th percentile

how to get involved

For more information or to participate, please contact:

Jennifer Mawby, RN, CCRP
Phone: (734) 232-4250
Email: umkidneystudies@umich.edu